Acelyrin boosts immunology pipeline through acquisition of ValenzaBio

Acelyrin has acquired ValenzaBio, a privately held clinical-stage biopharmaceutical company, in an all-stock deal. With the acquisition of ValenzaBio, the US- based late-stage clinical biopharma ... Read More